Sign Up to like & get
recommendations!
1
Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0234708
Abstract: Fibroblast growth factor receptors (FGFRs) are frequently altered in a variety of human cancer cells and are overexpressed in hepatocellular carcinoma (HCC). Several literatures have proven that they are efficacious for HCC therapy, however, the…
read more here.
Keywords:
hcc;
hep3b;
cul3;
hep3b cells ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.15801
Abstract: Signal transducer and activator of transcription 3 (STAT3) and hexokinase 2 (HK2) are involved in hepatocellular carcinoma (HCC). Deregulation of cellular energetics involving an increase in glycolysis is a characteristic of HCC. This study examined…
read more here.
Keywords:
hcc;
glycolysis;
stat3;
hep3b cells ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.843742
Abstract: Hepatocellular carcinoma (HCC) is the primary histological subtype of liver cancer, and its incidence rates increase with age. Recently, systemic therapies, such as immune checkpoint inhibitors, monoclonal antibodies, and tyrosine kinase inhibitors (TKIs), have been…
read more here.
Keywords:
lenvatinib regorafenib;
hcc;
cell density;
hepg2 hep3b ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncology research"
DOI: 10.3727/096504017x14850151453092
Abstract: MicroRNAs (miRs), a class of small noncoding RNAs, are key gene regulators through inducing translational repression or degradation of their target genes. However, the regulatory mechanism of miR-133b underlying hepatocellular carcinoma (HCC) growth and metastasis…
read more here.
Keywords:
mir 133b;
hcc;
hepg2 hep3b;
proliferation ... See more keywords